All News

The Food and Drug Administration approved Polivy plus Rituxan, cyclophosphamide, doxorubicin and prednisone for patients with previously untreated diffuse large B-cell lymphoma — marking the first new regimen in nearly two decades for this patient population.

We asked our audience what advancements they hope to see in the oncology space within the next decade or so. Here’s what they had to say.

Throughout my cancer experience — and my entire life — there were many people who came in and saved my life.

The FDA granted a priority review to Lonsurf with or without Avastin for the treatment of patients with pretreated metastatic colorectal cancer.

The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

One patient was able to access a therapy for follicular lymphoma before it was approved by the FDA, which allowed him to help future patients through his experience.

Is it always one or the other? Can good news in one person’s cancer experience do good for the community?

Acupuncture improved the sleep of cancer survivors faced with chronic pain, opening the door to nonpharmacological methods of sustainable pain management, according to a recent study.

Every three weeks I experience the “drip, drip, drip” of cancer treatment.

Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.

I’m 16 years out from my breast cancer diagnosis, but every now and then, panic still creeps up on me.

The addition of a personalized cancer vaccine to Keytruda led to a 44% reduction in the risk of death or recurrence in certain patients with melanoma.

The inflammation associated with lung cancer and depression may impact survival, despite treatments like immunotherapy and targeted therapies.

It’s essential that I maintain a sense of urgency, as well as long-term stamina, in my cancer survivorship.

As a cancer survivor, I feel that the song, "Here comes the sun" can inspire us all.

Supportive care commonly addresses physical symptoms associated with lung cancer and side effects associated with cancer therapy.

The Food and Drug Administration granted OM-301 an Orphan Drug Designation for the treatment of patients with myeloma.

After being given 2 years to live by her oncologist, a mother of two children is trying her best to protect her family — and herself — from thinking too negatively despite having rare gastrointestinal cancer.

I recently experienced scanxiety after a skin check-up showed something suspicious.

From composer Ryuichi Sakamoto’s death to the “King of Chemo” cycling across the United States to raise funds for mental health and cancer charities, here’s what’s happening in the oncology space this week.

The phase 3 Pragmatica-Lung study evaluating Cyramza and Keytruda has broader eligibility criteria than many other trials, expanding access to more patients and clinicians.

If approved by the FDA, Keytruda plus chemotherapy could provide a frontline therapy for patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

More awareness is needed to understand the benefits of both supportive care and palliative care in lung cancer.

After being diagnosed with mesothelioma and undergoing a long surgery, I wanted to do it all, but I just couldn’t. Family and friends stepped in to help.

For some patients with non-small cell lung cancer, removing part of the lobe rather than the entire lobe still provides benefit, study results show.

The Inflation Reduction Act is decreasing the out-of-pocket costs for multiple oncology drugs.

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.